17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
The IRS has just issued the cost of living adjustments for various retirement plan limitations that ...
Read More >
A recent ruling from the Takeover Panel (Panel) on the takeover offer for Moss Bros has reemphasised...
Read More >
Employee claims of “hostile work environments” continue to make news both in Maine and on a nation...
Read More >
The Situation: The new PRC Foreign Investment Law ("FIL"), as well as its Implementing Regulations (...
Read More >
In July 2019, the U.S. Department of Labor’s Wage and Hour Division (WHD) issued Opinion Letter FLS...
Read More >
In November, we wrote about a lawsuit filed against Amazon by a New Jersey man claiming he was wrong...
Read More >